Study guide
7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation
IBSC CCP-C Certified Critical Care Paramedic Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Strategy
1.1 About the CCP-C Exam 1.2 CCP-C Study Strategy & Exam Tactics
2 Chapter 2: Transport and Safety (Part 1)
2.1 Crew Resource Management & Sterile Cockpit Rule 2.2 Transport Risk Assessment & Mission Decision-Making 2.3 Aircraft and Ground Transport Safety Protocols
3 Chapter 2: Transport and Safety (Part 2)
2.4 Environmental Transport Stressors & Gas Laws 2.5 Transport Equipment Management & Post-Mission Operations
4 Chapter 3: Airway, Anesthesia, and Analgesics (Part 1)
3.1 Advanced Airway Assessment & Difficult Airway Identification 3.2 Rapid Sequence Induction (RSI) - Pretreatment & Induction Agents 3.3 Neuromuscular Blockade - Depolarizing vs Non-Depolarizing Agents 3.4 Post-Intubation Sedation, Analgesia & Dissociative Maintenance 3.5 Transport Ventilator Setup & Primary Ventilation Modes
5 Chapter 3: Airway, Anesthesia, and Analgesics (Part 2)
3.6 Mechanical Ventilator Waveforms, Loops & Oxygenation Titration 3.7 Ventilator Alarm Troubleshooting & Peak vs Plateau Pressures 3.8 Rescue Airway Devices, Video Laryngoscopy & Surgical Cricothyrotomy 3.9 Neuromuscular Reversal & Vasoactive Airway Support 3.10 Transport Airway Management in Unique Environments & Extubation
6 Chapter 4: General Medical Patient
4.1 Sepsis, Severe Sepsis & Septic Shock Resuscitation 4.2 Endocrine Emergencies (DKA, HHS, Adrenal Crisis, Thyroid Storm) 4.3 Renal and Hepatic Emergencies in Transport
7 Chapter 5: Cardiac Patient
5.1 Acute Coronary Syndromes & Infarct Specific Complications 5.2 Invasive Hemodynamic Monitoring 5.3 Vasoactive & Inotropic Medication Titration 5.4 Mechanical Circulatory Support & Post-Cardiac Arrest Care
8 Chapter 6: Neurological Patient
6.1 Traumatic Brain Injury & Intracranial Pressure (ICP) Management 6.2 Acute Ischemic Stroke, Hemorrhagic Stroke & Subarachnoid Hemorrhage 6.3 Status Epilepticus, Spinal Cord Injury & Neurogenic Shock
9 Chapter 7: Respiratory Patient
7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation 7.2 Severe Asthma & COPD Exacerbations in Critical Care 7.3 Chest Tube Management, Pleural Drains & Tension Pneumothorax 7.4 Pulmonary Embolism, Pulmonary Hypertension & Transport Respiratory Meds
10 Chapter 8: Toxic Exposure and Environmental Patient
8.1 Toxicology Emergencies, Toxidromes & Antidote Therapy 8.2 Environmental Emergencies (Hypothermia, Hyperthermia, Frostbite) 8.3 Submersion, Diving Emergencies & Envenomation/HazMat
11 Chapter 9: Trauma and Burn Patient
9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP) 9.2 Severe Thoracic & Abdominal Trauma Management 9.3 Thermal, Chemical & Electrical Burn Assessment & Fluid Resuscitation 9.4 Musculoskeletal Trauma, Pelvic Fractures & Compartment Syndrome
12 Chapter 10: Maternal and Fetal Medicine
10.1 High-Risk Obstetric Assessment & Hypertensive Disorders of Pregnancy 10.2 Obstetric Hemorrhage, Placental Abruption & Preterm Labor 10.3 Emergency Transport Delivery, Umbilical Cord Prolapse & Fetal Monitoring
13 Chapter 11: Pediatric Patient
11.1 Pediatric Critical Care Airway & Transport Ventilation 11.2 Pediatric Shock, Dehydration & Weight-Based Dosing 11.3 Neonatal Resuscitation Program (NRP) & Transport of the Critical Neonate
14 Chapter 12: Special Populations
12.1 Bariatric Critical Care Transport & Positional Management 12.2 Geriatric Critical Care & Patients with Specialized Medical Technology
15 Chapter 13: Professional Considerations
13.1 Legal Aspects, EMTALA & Transport Ethics 13.2 Quality Improvement, Transport Safety Research & Evidence-Based Practice
7.1 Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation
Key Takeaways Explain This Topic AI
ARDS is defined by the Berlin Definition: acute onset (<1 week), bilateral opacities on chest imaging, non-cardiogenic pulmonary edema, and impaired oxygenation categorized by PaO2/FiO2 ratio (Mild: 200-300 mmHg, Moderate: 100-200 mmHg, Severe: <100 mmHg with PEEP >= 5 cmH2O).
The ARDSNet protocol mandates lung-protective ventilation using low tidal volumes (4-8 mL/kg of Ideal Body Weight, starting at 6 mL/kg) and maintaining plateau pressure (Pplat) <= 30 cmH2O.
Ideal Body Weight (IBW) must always be used for tidal volume calculations because lung volume correlates with patient height and biological sex, not actual body weight.
Permissive hypercapnia is tolerated down to a pH of 7.20 to avoid volutrauma and barotrauma; contraindications include acute traumatic brain injury with elevated ICP and severe right heart failure.
Prone positioning is indicated for early severe ARDS (P/F ratio < 150 mmHg) and improves ventilation-perfusion matching by recruiting dorsal lung segments and homogenizing transpulmonary pressure.
Last updated: July 2026
Acute Respiratory Distress Syndrome (ARDS) & Lung-Protective Ventilation
Acute Respiratory Distress Syndrome (ARDS) represents a severe form of acute diffuse lung injury characterized by inflammation, increased pulmonary vascular permeability, and widespread alveolar damage. In critical care transport, managing patients with ARDS requires a deep understanding of pulmonary mechanics, the Berlin Definition, and strict adherence to lung-protective ventilation protocols to minimize ventilator-induced lung injury (VILI).
Pathophysiology of ARDS
ARDS is triggered by either direct or indirect pulmonary insults that initiate an intense systemic inflammatory cascade:
Direct Insults : Aspiration of gastric contents, severe pneumonia (viral, bacterial, fungal), near-drowning, pulmonary contusion, inhalation of toxic gases, or fat embolisms.
Indirect Insults : Severe sepsis or septic shock, non-thoracic trauma with shock, acute pancreatitis, massive blood transfusion (Transfusion-Related Acute Lung Injury - TRALI), or cardiopulmonary bypass.
The Three Pathological Phases
Exudative Phase (Days 1–7) :
Release of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) causes neutrophilic infiltration into pulmonary capillaries.
Endothelial and alveolar epithelial damage disrupts the alveolar-capillary membrane.
Protein-rich fluid, neutrophils, and red blood cells flood the alveolar spaces, degrading pulmonary surfactant.
Microvascular thrombosis and loss of surfactant cause widespread alveolar collapse (atelectasis), severe intrapulmonary shunting ( V / Q = 0 V/Q = 0 V / Q = 0 ), and marked compliance loss.
Formation of microscopic hyaline membranes lining alveoli.
Proliferative Phase (Days 7–21) :
Proliferation of Type II pneumocytes, cellular repair attempts, and myofibroblast infiltration.
Fibrotic Phase (Day 21+) :
Extensive remodeling, collagen deposition, pulmonary fibrosis, and persistent pulmonary hypertension. Inflammatory Insult (Direct or Indirect)
- │
- ▼
- Neutrophil Activation & Cytokine Cascade
- │
- ▼
- Alveolar-Capillary Membrane Disruption
- │
- ├───────────────────────────────┐
- ▼ ▼
- Surfactant Inactivation Proteinaceous Edema
- │ │
- ▼ ▼
- Alveolar Collapse (Atelectasis) Hyaline Membrane Formation
- │ │
- └───────────────┬───────────────┘
- ▼
- Refractory Hypoxemia (V/Q Shunt)
- Diagnostic Criteria: The Berlin Definition
Established in 2012, the Berlin Definition standardizes the clinical criteria required to diagnose ARDS and classify its severity:
Criteria Berlin Definition Requirement
Timing Within 1 week of a known clinical insult or new/worsening respiratory symptoms.
Chest Imaging Bilateral opacities on chest radiograph or CT scan not fully explained by effusions, lobar/lung collapse, or nodules.
Origin of Edema Respiratory failure not fully explained by cardiac failure or fluid overload (requires objective assessment, such as echocardiography, if no risk factor is present).
Oxygenation ( P a O 2 / F i O 2 PaO_2 / FiO_2 P a O 2 / F i O 2 ) Measured with P E E P ≥ 5 cmH 2 O PEEP \ge 5 \text{ cmH}_2\text{O} PEEP ≥ 5 cmH 2 O or C P A P ≥ 5 cmH 2 O CPAP \ge 5 \text{ cmH}_2\text{O} CP A P ≥ 5 cmH 2 O .
Severity Classification by Oxygenation Index
The P a O 2 / F i O 2 PaO_2 / FiO_2 P a O 2 / F i O 2 ( P / F P/F P / F ) ratio is calculated by dividing the arterial partial pressure of oxygen ( P a O 2 PaO_2 P a O 2 in mmHg) by the fractional concentration of inspired oxygen ( F i O 2 FiO_2 F i O 2 as a decimal). P/F Ratio = P a O 2 ( mmHg ) F i O 2 ( decimal ) \text{P/F Ratio} = \frac{PaO_2 (\text{mmHg})}{FiO_2 (\text{decimal})} P/F Ratio = F i O 2 ( decimal ) P a O 2 ( mmHg )
Mild ARDS : 200 mmHg < P / F ≤ 300 mmHg 200 \text{ mmHg} < P/F \le 300 \text{ mmHg} 200 mmHg < P / F ≤ 300 mmHg (with P E E P ≥ 5 cmH 2 O PEEP \ge 5 \text{ cmH}_2\text{O} PEEP ≥ 5 cmH 2 O )
Moderate ARDS : 100 mmHg < P / F ≤ 200 mmHg 100 \text{ mmHg} < P/F \le 200 \text{ mmHg} 100 mmHg < P / F ≤ 200 mmHg (with P E E P ≥ 5 cmH 2 O PEEP \ge 5 \text{ cmH}_2\text{O} PEEP ≥ 5 cmH 2 O )
Severe ARDS : P / F ≤ 100 mmHg P/F \le 100 \text{ mmHg} P / F ≤ 100 mmHg (with P E E P ≥ 5 cmH 2 O PEEP \ge 5 \text{ cmH}_2\text{O} PEEP ≥ 5 cmH 2 O )
Clinical Calculation Example :
A patient on a mechanical ventilator with F i O 2 = 0.80 FiO_2 = 0.80 F i O 2 = 0.80 (80%) and P E E P = 10 cmH 2 O PEEP = 10 \text{ cmH}_2\text{O} PEEP = 10 cmH 2 O has an ABG showing P a O 2 = 64 mmHg PaO_2 = 64 \text{ mmHg} P a O 2 = 64 mmHg . P/F Ratio = 64 0.80 = 80 mmHg \text{P/F Ratio} = \frac{64}{0.80} = 80 \text{ mmHg} P/F Ratio = 0.80 64 = 80 mmHg Because the P / F P/F P / F ratio is < 100 mmHg < 100 \text{ mmHg} < 100 mmHg on PEEP ≥ 5 \ge 5 ≥ 5 , this patient meets criteria for Severe ARDS .
ARDSNet Protocol & Lung-Protective Ventilation
Historical mechanical ventilation strategies utilized large tidal volumes ( 10 − 15 mL/kg 10-15 \text{ mL/kg} 10 − 15 mL/kg ), leading to high mortality rates due to Ventilator-Induced Lung Injury (VILI) . The landmark ARDSNet ARMA trial demonstrated a dramatic reduction in mortality when using low tidal volume ventilation.
Mechanisms of Ventilator-Induced Lung Injury (VILI)
Volutrauma : Over-distension of alveoli from excessive tidal volumes.
Barotrauma : Alveolar rupture and gas leak (pneumothorax, pneumomediastinum) from excessive peak/plateau pressures.
Atelectotrauma : Repeated shear stress caused by the cyclic opening and collapse of unstable alveoli during inspiration and expiration.
Biotrauma : Release of systemic inflammatory mediators from mechanical trauma to lung tissue, driving multi-organ dysfunction syndrome (MODS). ┌─────────────────────────────────────────┐
- │ Mechanisms of VILI in Heterogeneous ARDS│
- └────────────────────┬────────────────────┘
- │
- ┌─────────────────────────────┼─────────────────────────────┐
- ▼ ▼ ▼
- Volutrauma Barotrauma Atelectotrauma
- (Alveolar Overdistension) (High Transpulmonary P) (Cyclic Recruitment)
- │ │ │
- └─────────────────────────────┼─────────────────────────────┘
- ▼
- Biotrauma
- (Systemic Cytokine Release / MODS)
- Step-by-Step ARDSNet Ventilator Management
- Step 1: Calculate Ideal Body Weight (IBW)
Tidal volumes must NEVER be calculated based on actual body weight. Alveolar volume is determined by height and biological sex, not adipose tissue.
Male IBW (kg) = 50 + 0.91 × [ Height (cm) − 152.4 ] 50 + 0.91 \times [\text{Height (cm)} - 152.4] 50 + 0.91 × [ Height (cm) − 152.4 ] (or 50 + 2.3 × [ Height (inches) − 60 ] 50 + 2.3 \times [\text{Height (inches)} - 60] 50 + 2.3 × [ Height (inches) − 60 ] )
Female IBW (kg) = 45.5 + 0.91 × [ Height (cm) − 152.4 ] 45.5 + 0.91 \times [\text{Height (cm)} - 152.4] 45.5 + 0.91 × [ Height (cm) − 152.4 ] (or 45.5 + 2.3 × [ Height (inches) − 60 ] 45.5 + 2.3 \times [\text{Height (inches)} - 60] 45.5 + 2.3 × [ Height (inches) − 60 ] )
Height (Inches / Feet) Male IBW (kg) Initial V T V_T V T ( 6 mL/kg 6 \text{ mL/kg} 6 mL/kg ) Female IBW (kg) Initial V T V_T V T ( 6 mL/kg 6 \text{ mL/kg} 6 mL/kg )
- 60" (5'0") 50.0 kg 300 mL 45.5 kg 270 mL
- 64" (5'4") 59.2 kg 355 mL 54.7 kg 330 mL
- 68" (5'8") 68.4 kg 410 mL 63.9 kg 380 mL
- 72" (6'0") 77.6 kg 465 mL 73.1 kg 440 mL
- Step 2: Set Initial Ventilator Parameters
Mode : Volume Assist/Control (AC/VC) or Pressure Assist/Control (AC/PC).
Initial Tidal Volume ( V T V_T V T ) : Set to 6 mL/kg 6 \text{ mL/kg} 6 mL/kg IBW.
Respiratory Rate (RR) : Adjust to match minute ventilation needs (typically 18 − 24 breaths/min 18-24 \text{ breaths/min} 18 − 24 breaths/min , up to a max of 35 breaths/min 35 \text{ breaths/min} 35 breaths/min ).
Oxygenation Goal : P a O 2 55 − 80 mmHg PaO_2 55 - 80 \text{ mmHg} P a O 2 55 − 80 mmHg or S p O 2 88 − 95 % SpO_2 88 - 95\% Sp O 2 88 − 95% .
Step 3: Measure and Titrate Plateau Pressure ( P p l a t P_{plat} P pl a t )
Plateau pressure reflects alveolar static pressure and is measured by performing an inspiratory hold maneuver for 0.5 − 1.0 second 0.5 - 1.0 \text{ second} 0.5 − 1.0 second on a volume-controlled mode.
Goal : Maintain P p l a t ≤ 30 cmH 2 O P_{plat} \le 30 \text{ cmH}_2\text{O} P pl a t ≤ 30 cmH 2 O .
If P p l a t > 30 cmH 2 O P_{plat} > 30 \text{ cmH}_2\text{O} P pl a t > 30 cmH 2 O : Decrease V T V_T V T in steps of 1 mL/kg 1 \text{ mL/kg} 1 mL/kg IBW (down to a minimum of 4 mL/kg 4 \text{ mL/kg} 4 mL/kg IBW).
If P p l a t < 25 cmH 2 O P_{plat} < 25 \text{ cmH}_2\text{O} P pl a t < 25 cmH 2 O and V T < 6 mL/kg V_T < 6 \text{ mL/kg} V T < 6 mL/kg : Increase V T V_T V T by 1 mL/kg 1 \text{ mL/kg} 1 mL/kg IBW until P p l a t > 25 cmH 2 O P_{plat} > 25 \text{ cmH}_2\text{O} P pl a t > 25 cmH 2 O or V T = 6 mL/kg V_T = 6 \text{ mL/kg} V T = 6 mL/kg .
Driving Pressure ( Δ P \Delta P Δ P ) : Calculated as Δ P = P p l a t − P E E P \Delta P = P_{plat} - PEEP Δ P = P pl a t − PEEP . A target Δ P ≤ 15 cmH 2 O \Delta P \le 15 \text{ cmH}_2\text{O} Δ P ≤ 15 cmH 2 O is strongly associated with reduced hospital mortality.
PEEP and F i O 2 FiO_2 F i O 2 Titration Ladder
Positive End-Expiratory Pressure (PEEP) prevents alveolar de-recruitment at end-expiration. In ARDS, high PEEP strategies recruit collapsed alveoli and improve oxygenation without requiring toxic F i O 2 FiO_2 F i O 2 concentrations ( > 0.60 > 0.60 > 0.60 ).
Use the standardized ARDSNet Lower PEEP / Higher F i O 2 FiO_2 F i O 2 or Higher PEEP / Lower F i O 2 FiO_2 F i O 2 titration tables:
Lower PEEP / Higher F i O 2 FiO_2 F i O 2 Ladder
- F i O 2 FiO_2 F i O 2 0.30 0.40 0.40 0.50 0.50 0.60 0.70 0.70 0.70 0.80 0.90 0.90 1.00
- PEEP ( cmH 2 O \text{cmH}_2\text{O} cmH 2 O ) 5 5 8 8 10 10 10 12 14 14 14 16 18-24
- Higher PEEP / Lower F i O 2 FiO_2 F i O 2 Ladder (Preferred in Moderate-to-Severe ARDS)
- F i O 2 FiO_2 F i O 2 0.30 0.30 0.30 0.30 0.30 0.40 0.40 0.50 0.50 0.60 0.70 0.80 1.00
- PEEP ( cmH 2 O \text{cmH}_2\text{O} cmH 2 O ) 5 8 10 12 14 14 16 16 18 20 20 22 22-24
- Permissive Hypercapnia
Reducing tidal volume to 4 − 6 mL/kg 4-6 \text{ mL/kg} 4 − 6 mL/kg frequently causes alveolar hypoventilation and respiratory acidosis. Permissive hypercapnia is the deliberate acceptance of elevated arterial carbon dioxide levels ( P a C O 2 = 50 − 70 mmHg PaCO_2 = 50-70 \text{ mmHg} P a C O 2 = 50 − 70 mmHg ) to prioritize lung protection over normal blood gas chemistry.
pH Threshold : Arterial pH \text{pH} pH must be maintained ≥ 7.20 \ge 7.20 ≥ 7.20 .
Buffering : If pH < 7.20 \text{pH} < 7.20 pH < 7.20 despite maximizing respiratory rate ( R R ≤ 35 RR \le 35 RR ≤ 35 ), consider slow intravenous Sodium Bicarbonate ( N a H C O 3 NaHCO_3 N a H C O 3 ) or THAM (tris-hydroxymethyl aminomethane) infusions.
Absolute Contraindications to Permissive Hypercapnia :
Traumatic Brain Injury (TBI) or acute intracranial hypertension ( C O 2 CO_2 C O 2 causes cerebral vasodilation, increasing intracranial pressure).
Severe right ventricular failure or acute cor pulmonale ( C O 2 CO_2 C O 2 causes pulmonary vasoconstriction).
Severe hemodynamic instability or severe metabolic acidosis.
- Advanced Rescue Therapies in Transport
- 1. Prone Positioning
Prone positioning is recommended for patients with early severe ARDS ( P / F ≤ 150 mmHg P/F \le 150 \text{ mmHg} P / F ≤ 150 mmHg despite PEEP ≥ 10 cmH 2 O \ge 10 \text{ cmH}_2\text{O} ≥ 10 cmH 2 O and F i O 2 ≥ 0.60 FiO_2 \ge 0.60 F i O 2 ≥ 0.60 ).
Physiological Mechanism : Dorsal lung regions comprise the largest portion of lung parenchyma. In the supine position, gravity and cardiac mass collapse these dorsal regions. Proning homogenizes transpulmonary pressure gradients, recruits dorsal alveoli, and improves V / Q V/Q V / Q matching without overdistending ventral areas.
Trial Evidence : The PROSEVA study showed a 28-day mortality reduction ( 16 % 16\% 16% vs 32.8 % 32.8\% 32.8% ) when proning was applied for ≥ 16 hours/day \ge 16 \text{ hours/day} ≥ 16 hours/day .
Transport Considerations :
ETT depth verification prior to and immediately after rotation.
Securement of all central lines, arterial lines, and chest tubes.
Use of specialized foam positioning pads to protect eyes, face, and peripheral nerves (e.g., brachial plexus).
2. Neuromuscular Blockade (NMBAs)
In early severe ARDS ( P / F < 150 mmHg P/F < 150 \text{ mmHg} P / F < 150 mmHg ), continuous infusion of non-depolarizing neuromuscular blockers (e.g., Cisatracurium besylate 37.5 mg/hr 37.5 \text{ mg/hr} 37.5 mg/hr ) for the first 48 hours eliminates patient-ventilator dyssynchrony (breath stacking, reverse triggering), reduces oxygen consumption, and lowers transpulmonary pressure spikes.